Coronary occlusion refers to the narrowing or blockage of the coronary arteries due to plaque build up or fatty deposits in the inner walls of the arteries. When coronary arteries are blocked, the blood flow to the heart is restricted causing symptoms and various complications including chest pain and injury to the heart muscle. In severe cases, coronary occlusion is a life-threatening condition.
Patients with this condition require a procedure called coronary artery bypass graft (CABG), which aims to restore blood flow to the heart by creating new pathways around the blocked artery.
International patients from Asia or Western countries who require high-quality but affordable treatment for coronary occlusion can benefit from Southeast Asia’s thriving medical tourism industry that promises world-class but affordable medical and surgical care.
Many hospitals in Southeast Asian countries such as Thailand, Malaysia, and Singapore, invest heavily in recent advances in surgical techniques and technology for the treatment of this condition. These advances include minimally invasive techniques that allow surgeons to make CABG less traumatic. Minimally invasive direct coronary artery bypass (MIDCAB) can be performed using small incisions and without a heart-lung machine resulting in fewer complications, faster recovery, and less post-surgical pain.
Patients who prefer to undergo MIDCAB in Southeast Asia can have the procedure performed in any of the region’s Joint Commission International (JCI)-accredited hospital with a dedicated cardiology department. A JCI accreditation means that the quality of medical services offered by the hospital meets international standards. However, patients do not have to worry about exorbitant cost, as the comprehensive treatment of coronary occlusion in Southeast Asia is up to 50-75% cheaper than in Western countries such as the United States and United Kingdom.